We help our customers to deal with challenging recombinant proteins related projects. To see some solved ones, please provide us with your name and email address. We will be happy to send you selected case studies presentation showcasing our competences. Maybe issues you are facing now, are already described there...
-Innovative modular PureApta service platform for selection of modified aptamers with diagnostic and therapeutic potential (NCBR/Szybka Ścieżka POIR.01.01.01-00-0474/16)
-Service technology platform for discovery of antibody fragments with therapeutic and diagnostic potential (NCBR, action 1.1.1, project number: POIR.01.01.01-00-0749/16)
-The development and implementation of a bacteriophage preparation intended to use in the treatment and prevention of the American and European foulbrood of honey bee (NCBR, action 4.1.4, project number: POIR.04.01.04-00-0126/16). Partners: Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences, Wroclaw University of Environmental and Life Sciences, Bioscientia Ltd.
-Development of a field diagnostic test for infection of honey bee pathogen Nosema ceranae (NCBR/PBS)
-Development of vaccines for cattle and pigs based on recombinant antigens from Histophilus somni (NCBR/PBS)
-Optimization of therapeutic proteins production in hen oviduct (NCBR/PBS)
-Development of Rapid Multi-Test for diagnosis of viral infections contributing to colony collapse disorder of honeybees (EUREKA E!/Eurostars)
-Antibody-based diagnostics development using lung cancer specific microRNAs as biomarkers ("Mozart" partnership of science and business)
-Development of human induced pluripotent stem cells (iPS) production for medical use ("Mozart" partnership of science and business)